BDX vs STVN vs MCK Stock Comparison

Becton Dickinson, Stevanato Group S.p.A and Mckesson Prices as of Oct 26, 2026 Peers: Industry group
BDX Becton Dickinson & Co
$196.39 +6.8% 1M +5.7% 1Y
Market cap
$53.50B
P/E
56.9x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare
3 wins
STVN Stevanato Group S.p.A.
$19.87 -6.3% 1M -23.9% 1Y
Market cap
$5.43B
P/E
34.6x
Revenue (TTM)
$1.43B
Div. yield
–
Medical Supplies Healthcare
1 win
MCK Mckesson Corp
$992.64 +14.5% 1M +23.8% 1Y
Market cap
$117.44B
P/E
25.6x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
7 wins

Head to Head

11 decided of 12

Mckesson leads on 7 of the 12 questions below (Mckesson 7, Becton Dickinson 3, Stevanato Group S.p.A 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBDXSTVNMCKLeader
Larger companyMarket capitalisation $53.50B $5.43B $117.44B MCK
Cheaper on earningsLower P/E, profitable companies only 56.9x 34.6x 25.6x MCK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.1x 30.1x 21.1x BDX
Faster revenue growthRevenue growth, trailing twelve months +17.4% +14.8% +8.8% BDX
More profitableNet margin, trailing twelve months 4.0% 11.0% 1.1% STVN
Better return on capitalReturn on invested capital 5.3% 7.2% 107.9% MCK
Less leveragedLower net debt / EBITDA 3.2x 1.2x 0.6x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +5.7% -23.9% +23.8% MCK
Better 5-year returnAnnualised price return, 5 years -4.3%/yr -4.6%/yr +37.4%/yr MCK
Less volatileAnnualised volatility, 1 year 31.9% 45.6% 30.7% MCK
Higher overall scoreMean of the five percentile scores vs peers 67/100 66/100 58/100 BDX

Percentile Scorecard

BDXSTVNMCK

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBDXSTVNMCK
Valuation 90 #24 of 228 80 #46 of 228 50 #13 of 25
Growth 47 #117 of 221 57 #95 of 221 65 #9 of 24
Profitability 78 #46 of 208 82 #39 of 208 65 #9 of 24
Financial Health 27 #176 of 239 71 #69 of 239 48 #14 of 26
Shareholder Returns 95 #8 of 137 41 #81 of 137 60 #7 of 16
Overall 67 66 58
  • BDX ranked among 248 companies in Medical Devices and Diagnostics
  • STVN ranked among 248 companies in Medical Devices and Diagnostics
  • MCK ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBDXSTVNMCKSPY
1 month +6.8%-6.3%+14.5% -0.8%
3 months +23.6%+0.1%+16.7% +3.5%
6 months +30.7%+22.8%+19.8% +7.0%
Year to date +1.2%-1.2%+21.0% +12.2%
1 year +5.7%-23.9%+23.8% +13.0%
3 years -21.9%-30.8%+121.6% +86.3%
3 years, per year -7.9%-11.6%+30.4% +23.1%
5 years -19.8%-21.0%+388.9% +68.6%
5 years, per year -4.3%-4.6%+37.4% +11.0%
10 years +17.2%—+526.0% +258.0%
10 years, per year +1.6%—+20.1% +13.6%

Risk

MeasureBDXSTVNMCKSPY
Volatility, 1Y 31.9%45.6%30.7% 12.7%
Downside volatility, 1Y 33.1%44.8%27.3% 12.7%
Beta vs S&P 500, 1Y 0.341.12-0.26 1.00
Return / volatility, 1Y 0.18-0.520.78 1.02
Max drawdown, 5Y -50.4%-62.2%-27.2% -25.4%
From 52-week high -6.5%-23.5%-3.6% -1.8%
52-week high $210.02$25.98$1,030.18 $779.14
52-week low $140.71$13.43$725.17 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBDXSTVNMCK
P/E now vs peer median 57.3xmedian 30.6x 34.5xmedian 30.6x 25.7xmedian 24.3x
P/S now vs peer median 2.3xmedian 3.0x 4.2xmedian 3.0x 0.3xmedian 0.3x
EV/EBITDA now vs peer median 14.0xmedian 17.5x 18.6xmedian 17.5x 16.6xmedian 13.5x
P/FCF now vs peer median 16.7xmedian 23.3x 10.1xmedian 23.3x 18.0xmedian 15.6x
P/B now vs peer median 2.2xmedian 2.4x 3.4xmedian 2.4x -27.3xmedian 2.5x
PEG now vs peer median -3.93median 0.87 -128.82median 0.87 2.15median 1.33

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBDXSTVNMCK
Revenue $23.25B $1.43B $410.98B
Gross profit $10.91B $416.82M $14.96B
Operating income $2.48B $233.97M $6.50B
Net income $941.00M $157.06M $5.30B
Free cash flow $3.20B $592.88M $6.42B
R&D $1.37B $29.75M –
EPS (diluted) $3.42 $0.58 $38.52
Cash & equivalents $708.00M $89.82M $5.16B
Total debt $72.81B $2.11B $9.73B
Shares (diluted) 275.16M 272.96M 119.20M
Enterprise value $50.65B $4.87B $101.33B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBDXSTVNMCK
P/E 57.3x 34.5x 25.7x
P/FCF 16.7x 10.1x 18.0x
P/Operating cash flow 13.5x 20.7x 16.9x
P/S 2.3x 4.2x 0.3x
P/B 2.2x 3.4x -27.3x
P/Tangible book 2.2x 3.5x -14.0x
EV/EBITDA 14.0x 18.6x 16.6x
EV/EBIT 28.0x 27.4x 18.5x
EV/Revenue 3.0x 4.5x 0.3x
EV/FCF 21.7x 10.8x 18.8x
EV/Operating cash flow 17.6x 22.1x 17.6x
PEG (3Y EPS CAGR) -3.93 -128.82 2.15

Growth

14 metrics
MetricBDXSTVNMCK
Revenue growth (1Y) 17.4% 14.8% 8.8%
Revenue CAGR (3Y) 6.9% 9.8% 13.1%
Gross profit growth (1Y) 23.7% 19.4% 11.2%
Gross profit CAGR (3Y) 8.5% 6.2% 6.6%
Operating income growth (1Y) 13.0% 17.2% 46.6%
Operating income CAGR (3Y) 3.3% 4.5% 13.5%
Net income growth (1Y) -40.6% 7.5% 58.1%
Net income CAGR (3Y) -17.3% 0.8% 10.7%
EPS growth (1Y) -38.0% 6.7% 52.8%
EPS CAGR (3Y) -14.6% -0.3% 12.0%
Operating cash flow growth (1Y) 43.5% 30.4% 4.7%
Operating cash flow CAGR (3Y) 14.5% 32.9% 10.7%
Free cash flow growth (1Y) 54.2% 17.2% 6.8%
Free cash flow CAGR (3Y) 22.5% 8.0% 11.3%

Profitability

14 metrics
MetricBDXSTVNMCK
Gross margin 46.9% 29.2% 3.6%
EBITDA margin 21.4% 24.1% 1.8%
Operating margin 10.7% 16.4% 1.6%
Pretax margin 8.4% 15.7% 1.6%
Net margin 4.0% 11.0% 1.1%
FCF margin 13.8% 41.5% 1.6%
Operating cash flow margin 17.0% 20.3% 1.7%
Return on equity 3.9% 8.9% –
Return on assets 1.9% 5.3% 6.2%
Return on invested capital 5.3% 7.2% 107.9%
Return on capital employed 6.0% – 43.4%
Asset turnover 0.5x 0.5x 4.8x
Cash conversion (OCF / net income) 4.2x 1.8x 1.3x
Stock comp / revenue 1.2% – –

Financial Health

11 metrics
MetricBDXSTVNMCK
Debt / assets 33.1% 17.0% 11.0%
Debt / equity 0.7x 0.3x -2.3x
Net debt / EBITDA 3.2x 1.2x 0.6x
Debt / FCF 5.2x 0.9x 1.5x
Liabilities / assets 51.9% 40.8% 104.8%
Equity / assets 48.1% 59.2% -4.8%
Interest coverage 4.2x 14.9x 23.6x
Current ratio 0.9x – 0.9x
Quick ratio 0.3x – 0.5x
Cash ratio 0.1x – 0.1x
Altman Z-score 2.29 – 5.90

Shareholder Returns

7 metrics
MetricBDXSTVNMCK
Dividend yield 2.1% 0.3% 0.3%
Net buyback yield 4.7% – 5.7%
Shareholder yield 6.8% 0.3% 6.1%
Payout ratio (earnings) – – 7.4%
Payout ratio (FCF) – – 6.1%
Dividend growth (1Y) – – 11.3%
Dividend CAGR (3Y) – – 10.0%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBDXSTVNMCK
Forward P/E 15.1xFY2026 30.1xFY2026 21.1xFY2026
EPS, next fiscal year $12.99FY2026 $0.66FY2026 $47.14FY2026
EPS growth, next FY +14.8%FY2026 +4.8%FY2026 +20.5%FY2026
EPS growth, the year after -2.9% +15.2% +11.1%
Revenue, next fiscal year $18.11BFY2026 $1.47BFY2026 $444.51BFY2026
Revenue growth, next FY -17.1%FY2026 +5.8%FY2026 +10.2%FY2026
Revenue growth, the year after +11.6% +10.0% +1.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBDXSTVNMCK
Held by institutions 96.1% 16.4% 89.1%
Institutions holding 1,442 126 2,007
Change in shares held, QoQ +0.6% +0.4% -0.7%
Institutions buying 688 61 879
Institutions selling 543 52 791
Buyers to sellers 1.27 1.17 1.11

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BDXSTVNMCK
BDX 1.00 0.22 0.24
STVN 0.22 1.00 -0.07
MCK 0.24 -0.07 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BDX, STVN and MCK?

Mckesson (MCK) is the largest by market capitalisation: Becton Dickinson (BDX) $53.50B, Stevanato Group S.p.A (STVN) $5.43B, Mckesson (MCK) $117.44B.

Which stock is cheaper, BDX, STVN and MCK?

Mckesson (MCK) trades on the lowest price-to-earnings ratio (Becton Dickinson (BDX) 56.9x, Stevanato Group S.p.A (STVN) 34.6x, Mckesson (MCK) 25.6x). On next year's consensus earnings, Becton Dickinson (BDX) is cheapest (Becton Dickinson (BDX) 15.1x, Stevanato Group S.p.A (STVN) 30.1x, Mckesson (MCK) 21.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Becton Dickinson (BDX) grew revenue fastest over the trailing twelve months: Becton Dickinson (BDX) +17.4%, Stevanato Group S.p.A (STVN) +14.8%, Mckesson (MCK) +8.8%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (Becton Dickinson (BDX) 4.0%, Stevanato Group S.p.A (STVN) 11.0%, Mckesson (MCK) 1.1%). On return on invested capital, Mckesson (MCK) leads (Becton Dickinson (BDX) 5.3%, Stevanato Group S.p.A (STVN) 7.2%, Mckesson (MCK) 107.9%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Becton Dickinson (BDX) +5.7%, Stevanato Group S.p.A (STVN) -23.9%, Mckesson (MCK) +23.8%. Over five years, Mckesson (MCK) compounded fastest (Becton Dickinson (BDX) -4.3%/yr, Stevanato Group S.p.A (STVN) -4.6%/yr, Mckesson (MCK) +37.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Becton Dickinson (BDX) 0.00%, Stevanato Group S.p.A (STVN) 0.00%, Mckesson (MCK) 0.00%. Becton Dickinson (BDX) and Stevanato Group S.p.A (STVN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Becton Dickinson (BDX) 31.9%, Stevanato Group S.p.A (STVN) 45.6%, Mckesson (MCK) 30.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BDX, STVN and MCK?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.